Nonfasting TG/HDL-C ratio seems a good predictor of MACE in CAD patients with statin therapy. Could it be a treatment target?
- PMID: 29033056
- DOI: 10.1016/j.jjcc.2017.09.001
Nonfasting TG/HDL-C ratio seems a good predictor of MACE in CAD patients with statin therapy. Could it be a treatment target?
Keywords: Cardiovascular events; High-density lipoprotein cholesterol; Nonfasting triglycerides.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
